Neurotransmitters, PMS, and Pregnancy
How vitamin B6 (pyridoxine/P5P) supports mood, eases premenstrual symptoms, and reduces morning sickness
Vitamin B6 is one of the most versatile B vitamins, acting as a cofactor in over 100 enzyme reactions — many of them involved in making the brain chemicals that regulate mood, sleep, and stress. It is best known for easing PMS symptoms and morning sickness in pregnancy, where it has decades of clinical trial support. [1][3] Good dietary sources include poultry, salmon, tuna, potatoes, and bananas. Many people, especially women taking oral contraceptives, are mildly deficient without knowing it. It is available as pyridoxine hydrochloride (the common supplement form) or as pyridoxal-5'-phosphate (P5P), the active form the body uses directly.
How B6 Works in the Body
Vitamin B6 refers to a group of related compounds — pyridoxine, pyridoxal, pyridoxamine — that the body converts to the active coenzyme pyridoxal-5'-phosphate (P5P). This active form is required by enzymes that perform amino acid decarboxylation, which is the chemical step that converts amino acid precursors into neurotransmitters:
- Serotonin: P5P is needed to convert 5-HTP into serotonin (the mood and sleep regulator). Low B6 status measurably reduces serotonin production.
- Dopamine and norepinephrine: P5P assists the conversion of L-DOPA to dopamine and of dopamine to norepinephrine, the catecholamines behind motivation and alertness.
- GABA: P5P is a cofactor for glutamic acid decarboxylase (GAD), the enzyme that converts glutamate to GABA. Since GABA is the brain's main calming neurotransmitter, adequate B6 matters for anxiety and sleep quality.
B6 is also essential for homocysteine metabolism. Working alongside folate and B12, it converts homocysteine to cysteine via the transsulfuration pathway. High homocysteine is a cardiovascular risk marker, so B6 deficiency — especially in people with MTHFR polymorphisms — can contribute to elevated homocysteine even when folate and B12 look normal. See the folate page and homocysteine page for related details.
PMS: Emotional Symptoms and Hormonal Balance
Multiple clinical trials support B6 for premenstrual syndrome, particularly the emotional symptoms: depression, irritability, and fatigue in the two weeks before menstruation. [1][2]
The mechanism is thought to involve both the serotonin pathway (described above) and B6's role in steroid hormone metabolism — it helps the liver clear excess estrogen, which may contribute to the hormonal imbalance underlying PMS.
Doses used in trials have ranged from 50 to 200 mg per day, taken across the full cycle or just during the luteal phase. The systematic review by Wyatt et al. concluded that doses up to 100 mg/day are appropriate; higher doses carry a risk of peripheral neuropathy with long-term use and are not consistently more effective. Most clinicians recommend starting at 50 mg and only going higher with monitoring.
Morning Sickness in Pregnancy
Vitamin B6 is one of the most evidence-supported natural interventions for nausea and vomiting in early pregnancy. [3][4] It is safe at doses used clinically (10–25 mg three times daily) and forms the basis of Diclegis/Bonjesta, an FDA-approved combination drug (B6 + doxylamine) specifically for pregnancy nausea.
The typical protocol: 10–25 mg of pyridoxine hydrochloride taken three times daily, ideally with meals. Many women find that taking B6 before bed helps reduce morning nausea the following day. For severe symptoms (hyperemesis gravidarum), it is best used as part of a broader treatment plan with medical supervision.
Carpal Tunnel Syndrome
Some research suggests that B6 deficiency is disproportionately common in people with carpal tunnel syndrome (CTS), and that supplementation at 100–200 mg daily may reduce symptoms for those who are deficient. [5] The evidence here is more mixed than for PMS or pregnancy nausea — some trials show benefit while others do not — but the relationship between B6 status and nerve function is biologically plausible given B6's role in myelin synthesis.
Patients with occupational CTS from repetitive strain and documented B6 deficiency appear to be the group most likely to respond. CTS from anatomical narrowing alone is less likely to improve with B6 supplementation.
Forms, Dosing, and Safety
The two main supplemental forms are:
- Pyridoxine HCl: the standard, inexpensive form. Requires conversion to P5P in the liver; most people convert this efficiently.
- Pyridoxal-5'-phosphate (P5P): the active form, bypasses hepatic conversion. Preferred for people with liver conditions or poor conversion, and often better tolerated at higher doses.
The RDA is 1.3–1.7 mg/day for adults. Therapeutic doses for PMS and CTS are typically 50–100 mg/day. The tolerable upper intake level set by the NIH is 100 mg/day for adults, based on the risk of sensory neuropathy at sustained high doses. Doses above 200 mg/day taken long term can cause peripheral neuropathy (numbness, tingling in hands and feet), a reversible but real risk. B6 is water-soluble so moderate excess is excreted, but very high intake should not be assumed safe.
Evidence Review
PMS: Systematic Review and RCT
Wyatt et al. (1999, PMID 10334745) conducted a systematic review of nine randomized placebo-controlled trials of B6 for premenstrual syndrome, representing 940 patients. The pooled odds ratio for improvement in overall PMS symptoms compared to placebo was 2.32 (95% CI 1.95–2.54). Specifically for premenstrual depression, the OR was 1.69 (95% CI 1.39–2.06). The authors concluded that doses up to 100 mg/day are likely to be beneficial, though they noted that trial quality was variable — blinding was not always adequate, and outcome measures differed across studies. This is a meta-analysis limitation worth noting: the pooled estimate likely reflects a real effect but may be inflated by inclusion of weaker trials. [1]
Doll et al. (1989, PMID 2558186), in a randomized double-blind crossover trial in 63 women aged 18–49 with moderate-to-severe PMS, found a statistically significant benefit of pyridoxine 50 mg/day on emotional symptoms — depression, irritability, and tiredness — compared to placebo (p < 0.05). Physical symptoms (bloating, breast tenderness) showed less consistent improvement. This trial is notable for its crossover design, which controls for individual variability. [2]
Morning Sickness: RCT and Meta-Analysis
Sahakian et al. (1991, PMID 2047064) conducted a randomized, double-blind, placebo-controlled trial in 59 pregnant women. Participants received pyridoxine 25 mg (as pyridoxine HCl) or placebo orally every 8 hours for 72 hours. Women in the B6 group had significantly lower nausea severity scores at the end of the treatment period. The study specifically found that severe nausea responded better than mild nausea, suggesting a dose-response relationship and a threshold effect. [3]
Jayawardena et al. (2023, PMID 36719452) synthesized 18 studies on pyridoxine supplementation for nausea and vomiting in pregnancy (NVP) in a systematic review and meta-analysis. Both pyridoxine alone and pyridoxine combined with doxylamine significantly improved symptoms measured by the Rhode's Index and PUQE score (Pregnancy-Unique Quantification of Emesis). The review confirmed the safety profile of B6 at therapeutic doses in pregnancy and noted no evidence of harm to the fetus at doses used clinically. The combination therapy (B6 + doxylamine) was consistently superior to B6 alone, supporting the pharmacological rationale for Diclegis/Bonjesta as the first-line prescription treatment. [4]
Carpal Tunnel Syndrome
Ellis (1987, PMID 3603108) reported on vitamin B6 therapy at 100–200 mg/day for 12 weeks in patients with carpal tunnel syndrome and documented B6 deficiency. A large percentage of patients experienced symptom resolution, leading the author to suggest that CTS is partly a manifestation of B6 deficiency in some individuals. The paper also highlighted CTS during pregnancy as a condition where B6 status warrants evaluation. This was an observational clinical report rather than a blinded RCT, so the evidence grade is lower than for PMS and morning sickness. Subsequent controlled trials have produced mixed results — some showing benefit and others no advantage over conservative therapy — making B6 supplementation a reasonable adjunct to try in CTS, particularly if deficiency is suspected, but not a stand-alone treatment. [5]
Evidence Summary
The strongest evidence base is for PMS emotional symptoms (multiple RCTs, systematic review with OR >2) and pregnancy nausea (RCTs plus a 2023 meta-analysis). The carpal tunnel application has biological plausibility and some clinical support but requires confirmation from higher-quality RCTs. The neurotransmitter synthesis role is mechanistically well-established (biochemical evidence) though direct clinical trials linking B6 supplementation to mood outcomes in non-PMS populations are less numerous than for the specific applications above.
References
- Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic reviewWyatt KM, Dimmock PW, Jones PW, O'Brien PM. BMJ, 1999. PubMed 10334745 →
- Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trialDoll H, Brown S, Thurston A, Vessey M. British Journal of General Practice, 1989. PubMed 2558186 →
- Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled studySahakian V, Rouse D, Sipes S, Rose N, Niebyl J. Obstetrics and Gynecology, 1991. PubMed 2047064 →
- The effects of pyridoxine (vitamin B6) supplementation in nausea and vomiting during pregnancy: a systematic review and meta-analysisJayawardena R, Majeed S, Sooriyaarachchi P, Abeywarne U, Ranaweera P. Archives of Gynecology and Obstetrics, 2023. PubMed 36719452 →
- Treatment of carpal tunnel syndrome with vitamin B6Ellis JM. Southern Medical Journal, 1987. PubMed 3603108 →
Transparency
View edit historyEvery change to this page is tracked in version control. If you have conflicting research or think something is wrong, we want to hear about it.